| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:MK-0969
CAS:203321-88-4
Purity:>98% Remarks:Reach out to us for more information about custom solutions.
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:MK-0969
CAS:203321-88-4
Package:25mg;100mg;50mg
|
|
| | MK-0969 Basic information |
| Product Name: | MK-0969 | | Synonyms: | MK-0969;J 104135;J104135;J-104135;Benzeneacetamide, N-[1-[(6-amino-2-pyridinyl)methyl]-4-piperidinyl]-α-[(1R)-3,3-difluorocyclopentyl]-α-hydroxy-, (αR)- | | CAS: | 203321-88-4 | | MF: | C24H30F2N4O2 | | MW: | 444.53 | | EINECS: | | | Product Categories: | | | Mol File: | 203321-88-4.mol |  |
| | MK-0969 Chemical Properties |
| Melting point | 169-170 °C(Solv: hexane (110-54-3); chloroform (67-66-3)) | | Boiling point | 650.6±55.0 °C(Predicted) | | density | 1.30±0.1 g/cm3(Predicted) | | pka | 12.38±0.29(Predicted) |
| | MK-0969 Usage And Synthesis |
| Uses | MK-0969 is a M3 antagonist. MK-0969 can be used for research about chronic obstructive pulmonary disease and urinary incontinence[1][2]. | | References | [1] Sheng C, et al. Theoretical study on the mechanism of the benzaldehyde deoxyfluorination by sulfuryl fluoride and tetramethylammonium fluoride[J]. Journal of Physical Organic Chemistry, 2022, 35(8): e4389.
[2] Zhou L, et al., Impurity profile tracking for active pharmaceutical ingredients: case reports. J Pharm Biomed Anal. 2007 Jun 28;44(2):421-9. DOI:10.1016/j.jpba.2006.11.004 |
| | MK-0969 Preparation Products And Raw materials |
|